Investing.com - Immutep ADR (NASDAQ: IMMP) reported fourth quarter EPS of $-0.134, worse than the analyst estimate of $-0.128. Revenue for the quarter came in at $1.84M versus the consensus estimate of $1.76M.
Immutep ADR's stock price closed at $2.330. It is up 17.090% in the last 3 months and up 41.210% in the last 12 months.
Immutep ADR saw positive EPS revisions and negative EPS revisions in the last 90 days. See Immutep ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Immutep ADR's Financial Health score is "fair performance".
Check out Immutep ADR's recent earnings performance, and Immutep ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar